1. Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial. Issue 5 (25th January 2013) Authors: Kaku, K.; Inoue, S.; Matsuoka, O.; Kiyosue, A.; Azuma, H.; Hayashi, N.; Tokudome, T.; Langkilde, A. M.; Parikh, S. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 5(2013:May) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise. Issue 11 (8th July 2014) Authors: Kaku, K.; Kiyosue, A.; Inoue, S.; Ueda, N.; Tokudome, T.; Yang, J.; Langkilde, A. M. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 11(2014:Nov.) Page Start: 1102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗